Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion type Assertion NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_head.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion description "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion evidence source_evidence_literature NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion SIO_000772 11067958 NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion wasDerivedFrom befree-2016 NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion wasGeneratedBy ECO_0000203 NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.